Overview

Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
Determine the degree of striatal D2 receptor occupancy induced by OPC-34712 at differenht dose levels in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborator:
Otsuka Pharmaceutical Co., Ltd.